1002 related articles for article (PubMed ID: 26506952)
1. Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis.
Carnevale FC; Iscaife A; Yoshinaga EM; Moreira AM; Antunes AA; Srougi M
Cardiovasc Intervent Radiol; 2016 Jan; 39(1):44-52. PubMed ID: 26506952
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of Lower Urinary Tract Symptoms Following Prostate Artery Embolization for Benign Hyperplasia: Single Center Experience Comparing Two Techniques.
Carnevale FC; Moreira AM; Harward SH; Bhatia S; de Assis AM; Srougi M; Cerri GG; Antunes AA
Cardiovasc Intervent Radiol; 2017 Mar; 40(3):366-374. PubMed ID: 28074310
[TBL] [Abstract][Full Text] [Related]
4. Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia.
Insausti I; Sáez de Ocáriz A; Galbete A; Capdevila F; Solchaga S; Giral P; Bilhim T; Isaacson A; Urtasun F; Napal S
J Vasc Interv Radiol; 2020 Jun; 31(6):882-890. PubMed ID: 32249193
[TBL] [Abstract][Full Text] [Related]
5. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
[TBL] [Abstract][Full Text] [Related]
6. Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate--a prospective, randomized, and controlled clinical trial.
Gao YA; Huang Y; Zhang R; Yang YD; Zhang Q; Hou M; Wang Y
Radiology; 2014 Mar; 270(3):920-8. PubMed ID: 24475799
[TBL] [Abstract][Full Text] [Related]
7. Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis.
Jiang YL; Qian LJ
BMC Urol; 2019 Jan; 19(1):11. PubMed ID: 30691478
[TBL] [Abstract][Full Text] [Related]
8. Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: 2-yr Outcomes of a Randomised, Open-label, Single-centre Trial.
Abt D; Müllhaupt G; Hechelhammer L; Markart S; Güsewell S; Schmid HP; Mordasini L; Engeler DS
Eur Urol; 2021 Jul; 80(1):34-42. PubMed ID: 33612376
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.
Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M
J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084
[TBL] [Abstract][Full Text] [Related]
10. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Kim MH; Narayan VM; Dahm P
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD012867. PubMed ID: 35349161
[TBL] [Abstract][Full Text] [Related]
11. Prostatic Arterial Embolization with Small Sized Particles for the Treatment of Lower Urinary Tract Symptoms Due to Large Benign Prostatic Hyperplasia: Preliminary Results.
Li Q; Duan F; Wang MQ; Zhang GD; Yuan K
Chin Med J (Engl); 2015 Aug; 128(15):2072-7. PubMed ID: 26228221
[TBL] [Abstract][Full Text] [Related]
12. Systematic Review and Meta-analysis Comparing Prostatic Artery Embolization to Gold-Standard Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia.
Knight GM; Talwar A; Salem R; Mouli S
Cardiovasc Intervent Radiol; 2021 Feb; 44(2):183-193. PubMed ID: 33078236
[TBL] [Abstract][Full Text] [Related]
13. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
[TBL] [Abstract][Full Text] [Related]
14. Introduction of prostate artery embolization (PAE) in Sweden.
Lindgren H; Bläckberg M
Scand J Urol; 2019; 53(2-3):151-155. PubMed ID: 31096824
[No Abstract] [Full Text] [Related]
15. Prostatic Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) have a Differential Impact on Lower Urinary Tract Symptoms (LUTS): Retrospective Analysis of the Multicentre UK-ROPE (UK Register of Prostate Embolization) Study.
Vigneswaran G; Maclean D; Hadi M; Maher B; Modi S; Bryant T; Harris M; Hacking N
Cardiovasc Intervent Radiol; 2021 Jul; 44(7):1095-1102. PubMed ID: 33825062
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial.
Abt D; Hechelhammer L; Müllhaupt G; Markart S; Güsewell S; Kessler TM; Schmid HP; Engeler DS; Mordasini L
BMJ; 2018 Jun; 361():k2338. PubMed ID: 29921613
[TBL] [Abstract][Full Text] [Related]
17. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
[TBL] [Abstract][Full Text] [Related]
18. GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation.
Pereira-Correia JA; de Moraes Sousa KD; Santos JB; de Morais Perpétuo D; Lopes-da-Silva LF; Krambeck RL; Muller VJ; Vaz FP
BJU Int; 2012 Oct; 110(8):1184-9. PubMed ID: 22257240
[TBL] [Abstract][Full Text] [Related]
19. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
[TBL] [Abstract][Full Text] [Related]
20. Impact of 5-Alpha-Reductase Inhibitors Use at the Time of Prostatic Artery Embolization for Treatment of Benign Prostatic Obstruction.
Cardarelli-Leite L; de Assis AM; Moreira AM; Antunes AA; Cerri GG; Srougi M; Carnevale FC
J Vasc Interv Radiol; 2019 Feb; 30(2):228-232. PubMed ID: 30717954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
